Also known as A-3 pineal peptide · pineal peptide complex
The natural pineal peptide bioregulator — the animal-derived counterpart to synthetic Epitalon, marketed for aging and telomere support.
Research refreshed
Endoluten is a natural peptide complex extracted from the pineal gland, part of the Russian Cytomax line of tissue bioregulators. It is the animal-derived original that the synthetic tetrapeptide Epitalon was modeled on: where Epitalon is a single defined four-amino-acid sequence, Endoluten is a polypeptide fraction of the whole pineal extract. It is marketed within the Khavinson bioregulator tradition for aging, circadian, and telomere-related endpoints, on an evidence base concentrated in that research lineage.
Endoluten sits at the origin of the pineal-peptide story in this catalog. The Khavinson school of Russian gerontology began with natural peptide extracts of specific organs — the Cytomax bioregulators — and the pineal extract, sold as Endoluten, is among the most prominent, promoted for its proposed effects on aging and the body’s central clock. Its defining relationship is with Epitalon: Epitalon (Ala-Glu-Asp-Gly) is the synthetic short peptide distilled from this extract, so Endoluten is the natural, less-defined parent and Epitalon the reproducible synthetic descendant.
As a tissue extract it has no single molecular formula or sequence — it is a standardized polypeptide fraction, like Thymalin. The claims made for it (telomerase activation, melatonin regulation, lifespan endpoints) come from the same concentrated research tradition that surrounds Epitalon, with limited independent Western replication. It is a research compound and is not FDA-approved.
Proposed pineal-axis and gene-regulatory (bioregulator) activity — the same tradition that reports telomerase and melatonin effects for its synthetic analog Epitalon.
Behind every vial of Endoluten is the same exacting pipeline every research peptide runs — but the chemistry plays out differently for this molecule. Here is how Endoluten, specifically, is brought into being.
Endoluten begins not as a powder but as a specification. Before a single bond is made, the target sequence, salt form, and purity threshold are written down as the contract the finished material must meet.
Endoluten is assembled by solid-phase peptide synthesis — the chain grows one protected residue at a time on resin, and what you fail to build cleanly here you pay to remove later.
The crude mixture — Endoluten plus its deletions and side products — is then separated on preparative HPLC, and where the cut is taken decides the difference between a genuinely pure peptide and a barely-passable one.
A real batch of Endoluten proves itself: identity confirmed by mass spectrometry, purity read directly off an analytical HPLC trace, water and counterion content measured. That batch-specific certificate of analysis is the only honest way to know what is actually in a vial of Endoluten — and a short, cold, accountable chain of custody is how that purity survives the trip to your bench.
Endoluten is a natural pineal peptide complex — an extracted, fractionated polypeptide preparation rather than a synthesized molecule, and the natural counterpart to the synthetic tetrapeptide Epitalon. As with Thymalin and the other Cytomax extracts, consistency and characterization of the polypeptide fraction, not coupling chemistry, are the quality challenge.
Don't judge a vial by its cake. A fluffy, good-looking lyophilized powder reflects bulking agents and freeze-drying parameters — not purity. Insist on a batch-specific certificate of analysis.
Endoluten is a natural peptide complex extracted from the pineal gland, part of the Russian Cytomax bioregulator line, marketed for aging, circadian, and telomere-related endpoints.
Epitalon is the synthetic four-amino-acid peptide (Ala-Glu-Asp-Gly) modeled on this pineal extract; Endoluten is the natural, less-defined parent material.
No — it is a tissue extract (a polypeptide fraction), like Thymalin, so it has no single sequence or molecular formula.
No — it is a research compound, not FDA-approved, and its evidence base is concentrated in one research tradition. This page is a research and educational reference.
The active fragment of parathyroid hormone — a recombinant peptide that builds bone, exploiting a paradox: the same hormone resorbs bone when continuous, but builds it when pulsed.
ViewRecombinant 191-amino-acid human growth hormone — a folded protein biologic identical in sequence to pituitary GH, not a synthetic research peptide.
ViewThe downstream effector of growth hormone — a 70-amino-acid recombinant protein, structurally a cousin of proinsulin, that carries out most of GH’s growth signal.
ViewDosing protocols, mechanism, comparisons, and the latest trials — citation-backed answers grounded in PubMed, PubChem, and ClinicalTrials.gov.